These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30339061)

  • 1. Natural Derived Surfactant Preparation As a Carrier of Polymyxin E for Treatment of Pseudomonas aeruginosa Pneumonia in a Near-Term Rabbit Model.
    Basabe-Burgos O; Zebialowicz J; Stichtenoth G; Curstedt T; Bergman P; Johansson J; Rising A
    J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):110-118. PubMed ID: 30339061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.
    Birkun AA; Kubyshkin AV; Novikov NY; Krivorutchenko YL; Fedosov MI; Postnikova ON; Snitser AA
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):299-307. PubMed ID: 25517041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of antimicrobial agents. I. The in vitro sensitivity of 100 strains of Pseudomonas aeruginosa to polymyxin B, colistin, carbenicillin, gentamicin and doxycycline and to various combinations of these antibiotics.
    Kuipers JS
    Arch Chir Neerl; 1975; 27(4):257-70. PubMed ID: 174496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa.
    Lu Q; Girardi C; Zhang M; Bouhemad B; Louchahi K; Petitjean O; Wallet F; Becquemin MH; Le Naour G; Marquette CH; Rouby JJ
    Intensive Care Med; 2010 Jul; 36(7):1147-55. PubMed ID: 20397007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Azithromycin and Gentamicin for Efficient Treatment of Pseudomonas aeruginosa Infections.
    Ren H; Liu Y; Zhou J; Long Y; Liu C; Xia B; Shi J; Fan Z; Liang Y; Chen S; Xu J; Wang P; Zhang Y; Zhu G; Liu H; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    J Infect Dis; 2019 Oct; 220(10):1667-1678. PubMed ID: 31419286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia.
    Hraiech S; Brégeon F; Brunel JM; Rolain JM; Lepidi H; Andrieu V; Raoult D; Papazian L; Roch A
    J Antimicrob Chemother; 2012 Oct; 67(10):2452-8. PubMed ID: 22744759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical antibiotic therapy of Pseudomonas aeruginosa keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1979 Sep; 97(9):1699-1702. PubMed ID: 224848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrostatically entrapped colistin liposomes for the treatment of Pseudomonas aeruginosa infection.
    Li Y; Tang C; Zhang E; Yang L
    Pharm Dev Technol; 2017 May; 22(3):436-444. PubMed ID: 27576012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection.
    Omri A; Suntres ZE; Shek PN
    Biochem Pharmacol; 2002 Nov; 64(9):1407-13. PubMed ID: 12392822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
    Chen C; Deslouches B; Montelaro RC; Di YP
    Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental chemotherapy of pseudomonas aeruginosa infections].
    Nakazawa S; Kanamori M; Horita A; Miyoshi T; Mekata I
    Jpn J Antibiot; 1968 Apr; 21(2):84-7. PubMed ID: 4299625
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin.
    Hamer DH
    Am J Respir Crit Care Med; 2000 Jul; 162(1):328-30. PubMed ID: 10903263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
    Nagata T; Mukae H; Kadokawa T; Kaida H; Kuroki M; Yanagihara K; Asano K; Kadota J; Koji T; Kawano S
    Jpn J Antibiot; 2003 Apr; 56 Suppl A():57-9. PubMed ID: 14679749
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou Q; Onufrak NJ; Wirth V; Chen K; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of acetic acid, betadine, amphyll, polymyxin B, colistin, and gentamicin against Pseudomonas aeruginosa.
    Hedberg M; Miller JK
    Appl Microbiol; 1969 Nov; 18(5):854-5. PubMed ID: 4313170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
    Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.